INLET STRATEGIES

Lobbying for COHERUS BIOSCIENCES, INC · pharmaceutical development

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income · posted Oct 15, 2025

Lobbying activity 2

Health Issues

Issues related to domestic manufacturing of pharmaceuticals Federal financial support for the American Biotech Industry

Medicare/Medicaid

Federal Financial Support for the American Biotech Industry

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.